Andrew Tsai
Stock Analyst at Jefferies
(0)
# 5000
Out of 5,311 analysts
22
Total ratings
13.33%
Success rate
-37.68%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics | Initiates Coverage On: Buy | 200 | 96.04 | 108.25% | 1 | Apr 7, 2025 | |
BEKE KE Holdings | Maintains: Overweight | 19 27 | 18 | 50% | 2 | Mar 19, 2025 | |
RCKT Rocket Pharmaceutica... | Initiates Coverage On: Buy | 29 | 5.17 | 460.93% | 1 | Dec 18, 2024 | |
MRNS Marinus Pharma | Downgrades: Hold | 5 1 | n/a | n/a | 1 | Oct 25, 2024 | |
SRPT Sarepta Therapeutics | Initiates Coverage On: Buy | 165 | 50.25 | 228.36% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 13 | 0.28 | 4542.86% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 8.77 | 299.09% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 21 | n/a | n/a | 1 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 2.02 | 1533.66% | 1 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1 15 | 2.04 | 635.29% | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 3 | 0.48 | 525% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 3 | 0.23 | 1204.35% | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 1.55 | 1190.32% | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 70 | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 1.23 | 2095.12% | 1 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 23 | 30.11 | -23.61% | 1 | Jun 1, 2020 |